Skip to main content

Randomized Controlled Trials: Informing Clinical Practice for Traumatically Injured Patients

  • Chapter
  • First Online:
Trauma Induced Coagulopathy

Abstract

Well-designed randomized controlled trials have changed trauma resuscitation dramatically over the past few decades. Randomized controlled trials have established the effectiveness of permissive hypotension and the use of balanced blood product resuscitation to minimize mortality in traumatically injured patients. Together, these therapeutic concepts are termed “damage control resuscitation” and are now the standard of care for traumatically injured patients at risk of hemorrhagic shock and therefore trauma-induced coagulopathy.

In order to inform and change clinical practice, experimental human trials require special consideration. Each trial must be created with the safety of participants in mind. The clinical research team is responsible for establishing a trial design and statistical analysis plan which tests a question or hypothesis with scientific value and validity. To respect the trial participants and inform clinical practice, all trial planning, analysis, and outcomes must be reported appropriately both prior to data collection and at the completion of the trial. Therefore, only trials that are carefully and ethically designed, implemented, and analyzed which are adequately and transparently reported should be used to modify norms of clinical practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

COMBAT:

Control of Major Bleeding After Trauma

CRASH:

Clinical Randomization of an Antifibrinolytic in Significant Hemorrhage

DSMB:

Data and Safety Monitoring Boards

IRB:

Institutional Review Boards

PAMPer:

Prehospital Air Medical Plasma

PROMMTT:

PRospective, Observational, Multicenter, Major Trauma Transfusion

PROPPR:

Pragmatic, Randomized Optimal Platelet and Plasma Ratios

RCT:

Randomized controlled trial

STAAMP:

Study of Tranexamic Acid during Air Medical Prehospital

TXA:

Tranexamic acid

References

  1. Bothwell L, Greene J, Podolsky S, Johnes D. Assessing the gold standard – lessons from the history of RCTs. N Engl J Med. 2016;374(22):2175–81.

    Article  CAS  Google Scholar 

  2. Frieden TR. Evidence for health decision making-beyond randomized, controlled trials. N Engl J Med. 2017;377(5):465–75.

    Article  Google Scholar 

  3. Mattox KL, Maningas PA, Moore EE, Mateer JR, Marx JA, Aprahamian C, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension: the U.S.A. multicenter trial. Ann Surg. 1991;213(5):482–91.

    Article  CAS  Google Scholar 

  4. Bickell W, Wall M, Pepe P, Martin R, Ginger V, Allen M, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–9.

    Article  CAS  Google Scholar 

  5. The CRASH-3 Trial Collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet [Internet]. 2019;394(10210):1713–23. https://doi.org/10.1016/S0140-6736(19)32233-0.

    Article  Google Scholar 

  6. CRASH-2 Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with signifi cant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet [Internet]. 2010;376. https://doi.org/10.1016/S0140-6736(10)60835-5.

  7. Boffard KD, Riou B, Warren B, Choong PIT, Rizoli S, Rossaint R, et al. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials. J Trauma Inj Infect Crit Care. 2005;59(1):8–18.

    Article  CAS  Google Scholar 

  8. Brown JB, Neal MD, Guyette FX, Peitzman AB, Billiar TR, Zuckerbraun BS, et al. Design of the study of tranexamic acid during air medical prehospital transport (STAAMP) trial: addressing the knowledge gaps. Prehosp Emerg Care. 2015;19(1):79–86.

    Article  Google Scholar 

  9. Moore EE, Moore FA, Fabian TC, Bernard AC, Fulda GJ, Hoyt DB, et al. Human polymerized hemoglobin for the treatment of hemorrhagic shock when blood is unavailable: the USA multicenter trial. J Am Coll Surg. 2009;208(1):1–13.

    Article  Google Scholar 

  10. Sperry J, Guyette F, Brown J, Yazer M, Triulzi D, Early-Young B, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;376(4):315–26.

    Article  Google Scholar 

  11. Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet [Internet]. 2018 [Cited 2019 Jun 3];392(10144):283–91. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284829/pdf/nihms-997205.pdf

  12. Fox EE, Holcomb JB, Wade CE, Bulger EM, Tilley BC. Earlier endpoints are required for hemorrhagic shock trials among severely injured patients. Shock. 2017;47(5):567–73.

    Article  Google Scholar 

  13. Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.

    Article  CAS  Google Scholar 

  14. Holcomb JB, Del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148(2):127–36.

    Article  Google Scholar 

  15. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military application of tranexamic acid in trauma emergency resuscitation (MATTERs) study. Arch Surg. 2012;147(2):113–9.

    Article  CAS  Google Scholar 

  16. Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE. Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury findings from the MATTERs II study. JAMA Surg. 2013;148(3):218–25.

    Article  CAS  Google Scholar 

  17. Gauss T, Ageron FX, Devaud ML, Debaty G, Travers S, Garrigue D, et al. Association of prehospital time to in-hospital trauma mortality in a physician-staffed emergency medicine system. JAMA Surg. 2019;154(12):1117–24.

    Article  Google Scholar 

  18. Guyette FX, Sperry JL, Peitzman AB, Billiar TR, Daley BJ, Miller RS, et al. Prehospital blood product and crystalloid resuscitation in the severely injured patient: a secondary analysis of the prehospital air medical plasma trial. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003324.

  19. Reitz KM, Moore HB, Guyette FX, Sauaia A, Pusateri AE, Moore EE, et al. Prehospital plasma in injured patients is associated with survival principally in blunt injury. J Trauma Acute Care Surg. 2019;1:33–41.

    Google Scholar 

  20. Piantadosi S. Clinical trails a methodologic perspective. Two. Hoboken; 2005.

    Google Scholar 

  21. Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. Br Med J. 1996;313(7057):570–1.

    Article  CAS  Google Scholar 

  22. Anderson ML, Chiswell K, Peterson ED, Tasneem A, Toppings J, Califf R. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015;372(11).

  23. Spieth PM, Kubasch AS, Penzlin AI, Illigens BMW, Barlinn K, Siepmann T. Randomized controlled trials – a matter of design. Neuropsychiatr Dis Treat [Internet]. 2016;12:1341–9. https://doi.org/10.2147/NDT.S101938.

    Article  Google Scholar 

  24. U.S. Department of Health and Human Services, Food and Drug Administration, Office of Good Clinical Practice. Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors: exception from informed consent requirements for emergency research [Internet]. Vol. 2. 2013. Available from: papers2://publication/uuid/9FCB0391-8C40-4A38-BFC7-513052E72463.

    Google Scholar 

  25. Spinella P, Perkins J, Grathwohl K, Beekley A, Holcomb J. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma. 2009;66(4):S69–76.

    Article  Google Scholar 

  26. Cotton BA, Podbielski J, Camp E, Welch T, Del Junco D, Bai Y, et al. A randomized controlled pilot trial of modified whole blood versus component therapy in severely injured patients requiring large volume transfusions. Ann Surg. 2013;258(4):527–32.

    Article  Google Scholar 

  27. Yazer MH, Jackson B, Sperry JL, Alarcon L, Triulzi DJ, Murdock AD. Initial safety and feasibility of cold-stored uncrossmatched whole blood transfusion in civilian trauma patients. J Trauma Acute Care Surg. 2016;81(1):21–5.

    Article  Google Scholar 

  28. Karanicolas PJ, Farrokhyar F, Bhandari M, Karanicolas PJ. Blinding: who, what, when, why, how? [Internet]. Can J Surg. 2010;53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947122/pdf/0530345.pdf.

  29. Juszczak E, Altman DG, Hopewell S, Schulz K. Reporting of multi-arm parallel-group randomized trials: extension of the CONSORT 2010 statement. JAMA J Am Med Assoc. 2019;321(16):1610–20.

    Article  Google Scholar 

  30. Gupta S. Intention-to-treat concept: a review. Perspect Clin Res. 2011;2(3):109.

    Article  Google Scholar 

  31. Kent DM, Trikalinos TA, Hill MD. Are unadjusted analyses of clinical trials inappropriately biased toward the null? Stroke. 2009;40(3):672–3.

    Article  Google Scholar 

  32. Lingsma H, Roozenbeek B, Steyerberg E, behalf of the IMPACT investigators on. Covariate adjustment increases statistical power in randomized controlled trials. J Clin Epidemiol. 2010;63:1391.

    Article  Google Scholar 

Suggested Reading

  • Altman DG. Better reporting of randomised controlled trials: the CONSORT statement. Br Med J. 1996;313(7057):570–1.

    Article  CAS  Google Scholar 

  • Anderson ML, Chiswell K, Peterson ED, Tasneem A, Toppings J, Califf R. Compliance with results reporting at ClinicalTrials.gov. N Engl J Med. 2015;372(11).

  • Bickell W, Wall M, Pepe P, Martin R, Ginger V, Allen M, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med. 1994;331(17):1105–9.

    Article  CAS  Google Scholar 

  • CRASH Trial Collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with signifi cant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet [Internet]. 2010;376 https://doi.org/10.1016/S0140-6736(10)60835-5.

  • CRASH TEAM. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet [Internet]. 2019;394(10210):1713–23. https://doi.org/10.1016/S0140-6736(19)32233-0.

    Article  Google Scholar 

  • Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, Podbielski JM, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313(5):471–82.

    Article  CAS  Google Scholar 

  • Moore HB, Moore EE, Chapman MP, McVaney K, Bryskiewicz G, Blechar R, et al. Plasma-first resuscitation to treat haemorrhagic shock during emergency ground transportation in an urban area: a randomised trial. Lancet [Internet]. 2018 [Cited 2019 Jun 3];392(10144):283–91.

    Google Scholar 

  • Sperry J, Guyette F, Brown J, Yazer M, Triulzi D, Early-Young B, et al. Prehospital plasma during air medical transport in trauma patients at risk for hemorrhagic shock. N Engl J Med. 2018;376(4):315–26.

    Article  Google Scholar 

  • U.S. Department of Health and Human Services, Food and Drug Administration, Office of Good Clinical Practice. Guidance for Institutional Review Boards, Clinical Investigators, and Sponsors: exception from informed consent requirements for emergency research [Internet]. Vol. 2. 2013.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason L. Sperry .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Reitz, K.M., Althouse, A.D., Sperry, J.L. (2021). Randomized Controlled Trials: Informing Clinical Practice for Traumatically Injured Patients. In: Moore, H.B., Neal, M.D., Moore, E.E. (eds) Trauma Induced Coagulopathy. Springer, Cham. https://doi.org/10.1007/978-3-030-53606-0_40

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-53606-0_40

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-53605-3

  • Online ISBN: 978-3-030-53606-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics